SCHEMBL29925129

SCHEMBL29925129

C[C@@H]1NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC1=O

nearest known ligand 0.49

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
HDAC8 Q9BY41 4/20 0.49
HDAC3 O15379 3/20 0.49
HDAC1 Q13547 3/20 0.49
HDAC6 Q9UBN7 3/20 0.49
HDAC2 Q92769 2/20 0.49
HDAC10 Q969S8 2/20 0.49
HDAC11 Q96DB2 2/20 0.49
MC4R P32245 10/20 0.47
MC3R P41968 10/20 0.47
MC5R P33032 9/20 0.47
MC1R Q01726 9/20 0.47
IDO1 P14902 1/20 0.47
KDM4A O75164 1/20 0.46
KDM1A O60341 1/20 0.46
HTR2C P28335 1/20 0.45
NCOR2 Q9Y618 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8656601 0.89 KDM4A (0.53) HDAC8HDAC3HDAC1HDAC6MC4R
SCHEMBL29924992 0.86 MC4R (0.58) MC4RMC3RMC5RMC1RKDM4A
SCHEMBL29476454 0.85 MC4R (0.55) MC4RMC3RMC5RMC1R
SCHEMBL29925303 0.84 SSTR2 (0.51) HDAC8HDAC3HDAC1HDAC6HDAC2
SCHEMBL29925316 0.84 SSTR2 (0.51) HDAC8HDAC3HDAC1HDAC6HDAC2
SCHEMBL29924705 0.84 MC4R (0.57) MC4RMC3RMC5RMC1RKDM4A
SCHEMBL29925017 0.84 SSTR2 (0.51) HDAC8HDAC3HDAC1HDAC6HDAC2
SCHEMBL29925429 0.84 SSTR2 (0.51) HDAC8HDAC3HDAC1HDAC6HDAC2
SCHEMBL29925290 0.84 SSTR2 (0.51) HDAC8HDAC3HDAC1HDAC6HDAC2
SCHEMBL29924816 0.84 SSTR2 (0.51) HDAC8HDAC3HDAC1HDAC6HDAC2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220289794-A1 SYNTHETIC ANTIMICROBIAL PEPTIDES AJK BIOPHARMACEUTICAL LLC (US) 2022-09-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220289794-A1 SYNTHETIC ANTIMICROBIAL PEPTIDES VIP, HM13, NGLY1 HDAC8 4184/4885HDAC3 4682/4885HDAC1 4649/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.